(Q46923398)

26 December 2017

title

Effect of methylphenidate formulation on treatment patterns and use of emergency room services (English)

1 reference

26 December 2017

author name string

Jason E Kemner

series ordinal

1

1 reference

26 December 2017

Maureen J Lage

series ordinal

2

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

American Journal of Health-System Pharmacy

published in

1 reference

26 December 2017

volume

63

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

317-322

1 reference

26 December 2017

Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Young adult follow-up of hyperactive children: antisocial activities and drug use

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Childhood psychiatric disorder and unintentional injury: findings from a national cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Age-dependent decline of attention deficit hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Sildenafil for sexual dysfunction in women taking antidepressants

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Neuropsychological function in adults with attention-deficit hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Stimulant treatment over five years: adherence, effectiveness, and adverse effects

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Attention deficit hyperactivity disorder in childhood among adults with major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

A systematic review of the associations between dose regimens and medication compliance

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Effect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Healthcare use by children with attention deficit/hyperactivity disorder with and without psychiatric comorbidities.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

The costs of visits to emergency departments

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

Emergency room and primary care services utilization and associated alcohol and drug use in the United States general population

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050129

31 March 2020

Identifiers

DOI

10.2146/AJHP050129

1 reference

26 December 2017

1 reference

26 December 2017